1. Home
  2. IBRX vs AG Comparison

IBRX vs AG Comparison

Compare IBRX & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.24

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$15.18

Market Cap

8.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
AG
Founded
2014
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.5B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
IBRX
AG
Price
$7.24
$15.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$12.57
$21.92
AVG Volume (30 Days)
9.4M
10.1M
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
0.12%
EPS Growth
38.71
N/A
EPS
N/A
N/A
Revenue
$113,288,000.00
N/A
Revenue This Year
$88.59
$24.41
Revenue Next Year
$131.15
$10.68
P/E Ratio
N/A
$143.01
Revenue Growth
668.31
N/A
52 Week Low
$1.95
$7.97
52 Week High
$12.43
$32.00

Technical Indicators

Market Signals
Indicator
IBRX
AG
Relative Strength Index (RSI) 44.27 38.75
Support Level $6.69 $10.46
Resistance Level $8.46 $17.72
Average True Range (ATR) 0.42 0.76
MACD -0.09 -0.06
Stochastic Oscillator 38.93 24.73

Price Performance

Historical Comparison
IBRX
AG

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

Share on Social Networks: